MORGANTOWN, W. Va.–(BUSINESS WIRE)–A potential advancement in the treatment of Alzheimer’s disease was announced today by researchers at the West Virginia University Rockefeller Neuroscience Institute (RNI). A first in-human study, featured in the latest issue of the New England Journal of Medicine, demonstrates that focused ultrasound in combination with anti-amyloid-beta monoclonal antibody treatment can accelerate the clearance of amyloid-beta plaques in the brains of patients with Alzheimer’s disease.
Read more here.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://blog.ourcrowd.com/breakthrough-in-treating-alzheimers-using-targeted-drug-delivery-reported-in-new-england-journal-of-medicine/
- a
- accelerate
- advancement
- alzheimer
- Alzheimer’s
- announced
- antibody
- At
- Blog
- brains
- breakthrough
- business
- Business Wire
- by
- CAN
- clearance
- combination
- delivery
- demonstrates
- Disease
- drug
- Drug Delivery
- England
- featured
- First
- focused
- HTTPS
- in
- Institute
- issue
- journal
- latest
- medicine
- Neuroscience
- New
- of
- OurCrowd
- patients
- plato
- Plato Data Intelligence
- PlatoData
- potential
- Reported
- researchers
- s
- Study
- targeted
- that
- The
- The West
- today
- treating
- treatment
- ultrasound
- university
- using
- virginia
- W
- was
- West
- West Virginia
- Wire
- with
- zephyrnet